Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update in renal transplantation.

Colm C Magee1, Manuel Pascual

  • 1Renal Division, Brigham and Women's Hospital, Boston, MA 02115, USA. cmagee@partners.org

Archives of Internal Medicine
|July 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Disease Recurrence and Outcomes following Kidney Transplantation for Glomerulonephritis: A Prospective Nationwide Cohort Study.

Kidney360·2026
Same author

Purpura and Anasarca in a Kidney-Transplanted Recipient: A Quiz.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysis.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Xenotransplantation: from proof of concept to clinical reality.

Swiss medical weekly·2025
Same author

Regulatory T cell therapy for xenotransplantation, what perspectives?

Frontiers in immunology·2025
Same author

Association of Kidney Graft Long-term Outcome With Recipient Cystathionine Gamma-lyase Polymorphisms and Hydrogen Sulfide Levels: A Cohort Study.

Transplantation direct·2025
Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017
Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017
Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017
Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017
Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017
Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013
See all related articles

Renal transplantation offers improved survival rates for end-stage renal disease patients. Focus shifts to managing long-term complications like cardiovascular and bone disease, requiring a multidisciplinary approach for optimal outcomes.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Immunology

Background:

  • Renal transplantation is the preferred treatment for end-stage renal disease (ESRD).
  • A persistent shortage of donor organs hinders timely transplantation, despite increased living donors.
  • Significant improvements in allograft and recipient survival have been observed over the past decade.

Purpose of the Study:

  • To highlight the evolving landscape of renal transplantation.
  • To emphasize the shift in focus from acute rejection to long-term complication management.
  • To advocate for a multidisciplinary approach in optimizing long-term transplant outcomes.

Main Methods:

  • Review of recent advancements in immunosuppressive therapy.
  • Analysis of trends in allograft and recipient survival rates.

Related Experiment Videos

  • Discussion of the changing challenges in post-transplant care.

    • Main Results:

    • Improved efficacy and reduced toxicity of immunosuppressive regimens have led to better outcomes.
    • Acute rejection and early graft loss are less frequent.
    • Long-term complications such as suboptimal function, cardiovascular disease, and bone disease are now primary concerns.

    Conclusions:

    • Optimized immunosuppression has enhanced short-term renal transplant success.
    • Long-term management requires addressing non-immunological complications.
    • A comprehensive, multidisciplinary strategy is essential for maximizing the long-term success of renal transplant recipients.